Search results for: 'cell analyzer'

05 Aug 2024  |  Global  |  Technology Research

CGT Research Outlook and Technology Growth Opportunities

CGT Landscape Assessment

Infographics

×

The CGT landscape has evolved extensively over the past decade. More than 80 CGT products have been commercialized globally, with 34 FDA-approved cell and gene therapies in 2023 alone. The rise in product pipelines and clinical success rates has led to the growing demand for the development of new technology platforms, manufacturing capabilities, a...

There are numerous companies developing immunotherapy approaches to treat cancer, autoimmune and several other diseases. Current study describes some of the recent advances in immunotherapy, mostly cancer. These include refined cell therapies, stem cell applications in cancer treatment, monoclonal, polyclonal and bispecific antibodies. Some of exci...

Companies that are investing in the renewable energy sector are looking for the energy type that will lead the 'Green Revolution'. This analysis will take an in-depth view into this issue and highlight how solar energy will compete in the global market. Several companies that participate in the semiconductor and surface mount technology equipment m...

Worldwide cancer incidence is expected to exceed 35 million new cases by 2050, a 77% rise from the 20 million cases in 2022. Alcohol intake, tobacco usage, obesity, and air pollution are the main causes of this increase. Cancer studies today emphasize cell and gene therapy, antibody-drug conjugates (ADCs), checkpoint inhibitors, and multi-specific...

24 Aug 2021  |  North America  |  Market Research

US and EU Biotech Industry VC Investment Growth Opportunities

Future Growth Potential Driven by Next-generation Cell and Gene Platform Technology Powered by AI

Infographics

×

With this research service, Frost & Sullivan provides critical insights into the biotech, and cell and gene therapy (CGT) venture capital (VC) investment trends highlighting the growth opportunities, key countries in the VC environment, and major trends in cell and gene therapy segment. The study also identifies actionable growth opportunities for ...

The bio‑CDMO industry is entering an era of accelerated growth driven by the global shift toward complex biologics, including monoclonal antibodies, antibody-drug conjugates (ADCs), cell and gene therapies, recombinant proteins, and advanced vaccines. Large molecules are projected to record a 10.3% CAGR between 2025 and 2031, signaling sustained de...

This edition of the Energy & Power Systems (EPS) TOE features information about the innovations in batteries made with dry-process manufacturing, hydrogen fuel-cells, flow battery technology, solar cells for space applications, onshore wind energy, renewable forecasting and solar nowcasting, among others.The Energy and Power Systems TOE provides in...

02 May 2023  |  Global  |  Technology Research

Technology Advances in Senolytics

Innovative Drug Development Culture Working to Prolong Health Spans and Eliminate Aging Cells

Infographics

×

Senolytics is a relatively new field of development that falls under the broad category of senotherapeutics, along with senomorphics and senostatics. Although nascent, the field could address the root causes of most chronic conditions brought on by aging as it clears senescent cells that have ceased to multiply (and ideally are eliminated from the ...

28 Aug 2020  |  North America  |  Market Research

Strategic Collaborations Towards Technology Development Transforming The Global Fuel Cell Vehicles Market, 2020–2030

Establishing a Robust Refuelling Infrastructure and Lowering the Cost of H2 Production to Drive Growth Opportunities

Infographics

×

Key Issues Addressed

The automotive industry is rapidly evolving in terms of technology as well as tackling environmental issues. Electric vehicles (EVs) have been introduced as a clean energy initiative as they have low or zero emissions, and have come a long way to become an integral part of OEMs business strategies. Automakers like PSA and VW are creating separate E...